Abstract
Ecological research frequently focuses on the harmful effects of environmental contaminants on the human nervous system. Many studies have been devoted to examining the neurotoxic effects of certain inorganic compounds (such as mercury and lead), trialkyltin, and low-molecular-weight organophosphate and organochlorine pesticides which induce nonspecific lesions of various regions of the nervous system, including the central nervous system (CNS) (Cremer 1981; Costa 1988; Kagan et al. 1988; Makhaieva et al. 1987, 1988).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agid Y, Blin S (1987) Nerve cell death in degenerative disease of the central nervous system: clinical aspects. In: Selective Neuronal Death. Wiley, Chichester (Ciba Foundation Symposium 126 ), pp 3–29.
Ansher S, Cadet J, Jakoby W, Baker J (1986) Role of N-methyltransferases in the neurotoxicity associated with the metabolites of MPTP and other 4-substituted pyridines present in the environment. Biochem Pharmacol 35: 3359–3363.
Arai Y, Hamamichi N, Kinemuchi H (1986) Time-dependent inhibition of rat brain MAO by analogue of MPTP, 4-(4-chlorophenyl)-l,2,3,6-tetrahydropyridine. Neurosci Lett 70: 255–260.
Awasthi Y, Singh S, Rong-sen Shen, Abell C, Gessner W, Brossi A (1987) MPTP metabolites inhibit rat brain glutathione S-transferases. Neurosci Lett 81: 159–164.
Bachurin S, Lermontova N, Solyakov L, Sablin S, Tkachenko S (1988a) Different neurochemical mode of action of pyridinium herbicides. Neurochem Intern 13, Suppl. 1: 85.
Bachurin S, Sablin S, Dubova L (1988b) Monoamine oxidase (MAO) catalysis of dehydrogenation reaction of physiologically active aryltetrahydropyridines (THP). Abstracts 14th International Congress of Biochemistry, Prague, 1Y: 118.
Bachurin S, Solyakov L, Tkachenko S, Lermontova N, Petrova L, Serkova T (1988c) Biochemical criteria for development of parkinsonism under the influence of MPTP and its pyridine analogues as the method for solution of nontoxic pesticides among pyridine containing compounds. Abstracts Conference on Chemistry and Technology of Pyridine Containing Pesticides ( USSR ), Chernogolovka (Russ), pp 240–241.
Bachurin S, Sablin S, Dubova L (1988d) The catalytic properties of monoamine oxidase in dehydrogenation of physiologically active aryltetrahydropyridines. Abstracts Conference on Enzyme Engineering ( USSR ), Vilnus (Russ) 1: 11.
Bachurin S, Sablin S, Grishina G, Gaidarova E, Dubova L, Zubov N (1989a) Monoamine oxidase catalysis of bioconversion of physiologically active 1-methvl-4-aryl-l,2,3,6-tetrahydropyridines. Bioorganic Chimia (Russ) 15: 620–626.
Bachurin S, Sablin S, Dubova L (1990) Monoamine oxidase (MAO) catalysis of bioconversion of l-methyl-4-aryl-l,2,3,6,-tetrahydropyridines to physiologically active metabolites. Biocatalysis 4: 63.
Bachurin S, Solyakov L, Lermontova N, Tkachenko S, Kalashnikov V, Serkova T, Petrova L (1989b) The role of dopamine-uptake system in the development of experimental parkinsonism induced by MPTP and its pyridine analogues. Dokl Academ Nauk USSR (Russ) 307: 740–743.
Bachurin S, Lermontova N, Solyakov L, Petrova L, Serkova T, Tkachenko S (1989c) Estimation of neurotoxicity of pyridine containing pesticides as a possible ecotoxicological factor. Abstracts Intern. Symposium “Environmental Stress”, Tampere, p 47.
Bachurin S, Lermontova N, Sablin S, Solyakov L (1989d) Molecular basis of selectivity of 4-aryltetrahydropyridine derivatives. Abstracts Intern Symposium “Molecular basis of action of bioactive substances of behavior”, Tallin (Russ) p 8.
Baker R (1975) Tetrahydropyridine insect repellent. US Patent 3,865,944 (cl. 424-263; A 01 ).
Barbeau A, Dallaire L, Buu N, Poirier J, Ruchinka E (1985) Comparative behavioral, biochemical and pigmentary effects of MPTP, MPP+ and paraquat in Rana pipiens. Life Sci 37: 1529–1538.
Barbeau A, Roy M, Bernier G, Campanella G, Paris S (1987) Parkinson’s disease: prevalence and environmental aspects in rural areas. Can J Neurol Sci 14: 36–41.
Barbeau A, Roy M, Cloutier T, Plasse L, Paris S (1986) Environmental and genetic factors in the etiology of Parkinson’s disease. In: Yahr M, Bergmann K (eds) Advances in Neurology, 45, Raven Press, New York, pp 249–306.
Baskakov Y (1978) New synthetic plant growth regulators and herbicides. J. Mendeleev Natl Chem Soc (Russ) 2: 149–159.
Berlin Y, Kost N (1960) 3-Piperideines. Uspechi Chimii (Russ) 29: 220–233.
Booth R, Trevor A, Singer T, Castagnoli N (1989) Studies on semirigid tricyclic analogues of the nigrostriatal toxin MPTP. J Med Chem 32: 473–477.
Bradbury A, Costal B, Domeney A, Jenner P, Marsden C, Nalor R, Tan C (1985). The neurotoxic actions of MPTP in the rat are not confined to dopamine and the substantia nigra. Br J Pharm 86: 691.
Bradbury A, Brossi A, Costall B, Domerey A, Gessner W, Naylor R (1986) Biochemical changes caused by the infusion into the substantia nigra of the rat of MPTP and related compounds which antagonize dihydro-pteridine reductase. Neuropharmacology 25: 583–586.
Brossi A, Gessner W, Fritz R (1986) Interaction of monoamine oxidase B with analogues of MPTP derived from prodine-type analgetics. J Med Chem 29: 444–445.
Burns B, Chiueh C, Markey S, Ebert M, Jacobowitz D, Kopin I (1983) A primary model of parkinsonism: selective destruction of dopaminergic, neurons in the pars compacta of the substantia nigra by MPTP. Proc Natl Acad Sci (USA) 80: 4546–4450.
Chiba K, Peterson L, Castagnoli K, Trevor A, Castagnoli N (1985) Studies on the molecular mechanism of bioactivation of the selective nigrostriatal toxin MPTP. Drug Metab Dispos 13: 342–347.
Chiba K, Trevor A, Castagnoli N (1986) Uptake of MPP + by mouse brain synaptosomes. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 575–579.
Costa L (1988) Interaction of neurotoxicants with neurotransmitter systems. Toxicology 49: 359–366.
Coutts R, Scott J (1971) The chemistry and pharmacology of some tetrahydropyridines including arecoline and its derivatives. Can J Pharm Sci 6: 78–95.
Cremer J (1981) The neurotoxic effect of environmental chemicals. In: Davison A, Thompson R (eds) The Molecular Basis of Neuropathology. London, pp 234–264.
Corsini G, Pintus S, Bocchetta A (1986) Primate-rodent [H-3]-MPTP binding differences, and biotransformation of MPTP to a reactive intermediate in vitro. J Neural Trans Suppl 22: 55–66.
Crooks P, Godin C. Damani L (1988) Formation of quaternary amines by N-methylation of azaheterocycles with homogenous amine N-methyltransferases. Biochem Pharmacol 37: 1673 1677.
D’Amato R, Lipman Z, Snyder S (1986) Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP + binds to neuromelanin. Science 231: 987–989.
D’Amato R. Benham D, Snyder S (1987) Characterization of the binding of N-methyl-4-phenylpyridine, the toxic metabolite of the parkinsonian neurotoxin MPTP to neuromelanin. J Neurochem 48: 653–658.
Davis G, Williams A, Markey S, Ebert M, Caine E, Reichert C, Kopin I (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiat Res 1: 249–254.
Denton T, Howard B (1987) A dopaminergic cell line variant resistant to the neurotoxin MPTP. J Neurochem 49: 622–630.
Di Monte D, Sandy M, Ekstromand G, Smith M (1986) Comparative studies on the mechanisms of paraquat and l-methyl-4-phenylpyridine ( MPP +) cytotoxicity. Biochem Biophys Res Comm 137: 303–309.
Ellis R (1976) 4-Imidozolylsulfonylimidazoles. U.S. Patent 3,932,444 (cl 260–309).
Evans D, Mitch C, Thomas D, Zimmerman D, Robey R (1980) Application of methylated amines to alkaloid synthesis. An expedient approach to the synthesis of morphine-based analgesics. J Am Chem Soc 102: 5955–5956.
Evans D, Mitch C (1982) Studies directed towards the total synthesis of morphine alkaloids. Tetrahedron Lett 23: 285–288.
Ferles M, Pliml J (1970) 3-Piperidines (1,2,3,6-tetrahydropyridines). Adv Heterocycl Chem 12: 43–101
Fritz R, Abell C, Patel N, Gessner W, Brossi A (1985) Metabolism of the neurotoxin MPTP by human liver monoamine oxidase. FEBS Lett 186: 224–228.
Fuller R, Hemrick-Luecke S (1985) Inhibition of types A and B monoamine oxidase by MPTP. J Pharmacol Exp Therap 232: 696–701.
Fuller R, Hermrick-Luecke S (1986a) Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP. Res Comm Chem Pathol Pharmacol 53: 167–171.
Fuller R, Robertson D, Hemrick-Luecke S (1986b) Persistent depletion of striatal dopamine in mice by l-methyl-4-(2-thienyl)-l,2,3,6-tetrahydropyridine ( MPTP ). Biochem Pharmacol 35: 143–144.
Fuller R, Hemrick-Luecke S (1987) Persistent depletion of striatal dopamine and its metabolites in mice by TMMP. J Pharm Pharmacol 39: 667–669.
Gessner W, Brossi A, Bembenek M, Fritz R, Abell C (1986a) Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B. FEBS Lett 199: 100 102.
Gibb C, Willoughly J, Glover V, Sandler M, Testa B, Jenner P, Marsden C (1987) Analogues of MPTP as monoamine oxidase substrates: a second ring is not necessary. Neurosci Lett 76: 316–322.
Glover V, Gibb C Sandler M (1986) The role of MAO in MPTP toxicity. J Neurol Trans Suppl 20: 65–76.
Gray A, Platz P, Henderson T, Chang T, Takahashi K, Dretchen K (1988) Approaches to protection against nerve agent poisoning (naphthylvinyl) pyridine derivatives as potential antidotes. J Med Chem 31: 807–814.
Gridunov I, Prostakov N, Rodionova V (1964) Effect of l,2,5-trimethyl-4-phenyl-3,4-dehydropiperidine on the plastification of natural resin. Izv Vish Uch Zav Chim Chim Techn 7: 867 868.
Hackmark G, Klosa Y (1977) 4,4-Diphenylpiperidines. Ger Offen 2.166.997 (cl.C07D211/14).
Heikkila R, Hess A, Duvoisin R (1984a) Dopaminergic neurotoxicity of MPTP in mice, Science 224: 1451 1453.
Heikkila R, Manzino L, Cabbat F, Duvoisin R (1984b) Protection against the neurotoxicity of MPTP by monoamine oxidase inhibitors. Nature 311: 467–469.
Heikkila R, Hess A, Duvoisin R (1985a) Dopaminergic neurotoxicity of MPTP in the mouse: Relationships between monoamine oxidase, MPTP metabolism and neurotoxicity. Life Sci 36: 231 236.
Heikkila R, Manzino L, Cabbat F, Duvoisin R (1985b) Studies of the oxidation of dopamine neurotoxin MPTP by monoamine oxidase B. J Neurochem 45: 1049–1054.
Heikkila R, Youngster S, Panek D, Giovanni A, Sonsalla P (1988a) Studies with the neurotoxicant MPTP and several of its analogs. Toxicology 49: 493–501.
Heikkila R, Kindt M, Sonsalla P, Giovanni A, Youngster S, McKeown K, Singer T (1988b) Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of MPTP. Proc Natl Acad Sci (USA) 85: 6172–6176.
Heilmann S, Rasmussen I (1984) Heterocyclic polymers. In: Kataritzky A, Rees C (eds) Comprehensive Heterocyclic Chemistry. New York, Pergamon Press, V.l, pp 269–315.
Hirato Y, Sugimura H, Takei H, Nagatsu T (1986) The effects of pyridinium salts, structurally related compounds of l-methyl-4-phenylpyridinium ion ( MPP +), on tyrosine hydroxylation in rat striatal tissue slices. Brain Res 397: 341–344.
Houlihan W (1970) Herbicidal sulfamides Ger Offen DE 1964441 (cl 07de, A 01n ).
Hofle G, Steglich W, Vorbruggen H (1978) 4-Dialkylaminopyridines as highly active acylation catalysts. Angew Chem Int Ed Engl 17: 569–583.
Javitch J, D’Amato R, Strittmater S, Snyder S (1985) Parkinsonism inducing neurotoxin, MPTP: Uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci (USA) 82: 2173–2177.
Jenner P, Marsden C. Costal B, Naylor J (1986) MPTP and MPP + induced neurotoxicity in rodents and the common marmosets as experimental models of investigating Parkinson’s disease. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 563 567.
Johannessen J, Savitt J, Markey C (1987) The development of amine substituted analogues of MPTP as unique tools for study of MPTP toxicity and Parkinson’s disease. Life Sci 40: 697–704.
Kagan Y (1988) Toxicological aspects of studies on new pesticides. J Mendeleev Natl Chem Soc (Russ) 33: 624 631.
Kinemuchi H, Fowler C, Tipton K (1987) The neurotoxicity of MPTP and its relevance to Parkinson’s disease. Neurochem Intl 1 1: 359–373.
Kiuchi K, Hagiwara M, Hidaka H, Nagatsu T (1988) Effect of the 1-methyl-4-phenylpyridinium ion on phosphorylation of tyrosine hydroxylase in rat pheo-chromocytoma PC 12 h cells. Neurosci Lett 89: 209–215.
Koller W (1986) Paraquat and Parkinson’s disease. Neurology 36: 1147
Kopin I, Burns S, Chiuch C, Markey S (1986) MPTP-induced parkinsonian syndromes in humans and animals. In: Fisher A, Hanin J, Lachman C (eds) Alzheimer’s and Parkinson’s diseases: strategies for research and development. Plenum Press, New York, pp 519–530.
Kryzhanovsky G, Atadzhanov M, Voronina T, Nerobkova L, Zagorevsky V, Sharkova L (1988a) MPP + -Induced parkinsonian syndrome in rats: clinical and EEG changes. Bull Exp Biol Med (Russ) 2: 147–149.
Kryzhanovsky G, Atadzhanov M, Zagorevsky V, Sharkova L, Voronina T, Nerobkova L (1988b) Parkinson’s syndrome in rats induced by the administration of the MPTP. Bull Exp Biol Med (Russ) 4: 337–340.
Langston J, Ballard P, Tetrud J, Irwin I (1983) Chronic parkinsonism due to a product of meperidine-analog synthesis. Science 219: 979–980.
Langston J, Irwin I, Langston E, Forno L (1984a) Pargyline prevents MPTP-induced parkinsonism in primates. Science 225: 1480–1482.
Langston J, Irwin I, Langston E, Forno L (1984b) The importance of the 4-5 double bond for nuerotoxicity in primates of the derivative MPTP. Neurosci Lett 50: 289–294.
Lazdin’sh I, Avots A (1979) Catalytic methods of synthesis of pyridine bases. Chim Heterocycl Compounds J (Russ) 8: 1011–1026.
Lermontova N, Solyakov L, Bachurin S, Tkachenko S, Serkova T, Petrova L, Kalashnikov V (1989) An estimation of MPTP and some pyridine derivatives capability to produce parkinsonism. Bull Exp Biol Med (Russ) 6: 699–701.
Lermontova N, Solyakov L, Bachurin S, Serkova T, Petrova L, Draniy O, Tkachenko S, Kalashnikov V (1990) Clinical and biochemical parameters of parkinsonism induced by MPTP and its tolyl-and methoxyphenyl-derivatives in the mouse C57B1/6. Bull Exp Biol Med (Russ) 10: 397–399.
Leung L, Ottoboni S, Oppenheimer N, Castagnoli N (1989) Characterization of a product derived from the l-methyl-4-phenyl-2,3-dihydropyridinium ion, a metabolite of the nigrostriatal toxin MPTP. J Org Chem 54: 1052–1055.
Lewin R (1985) Parkinson’s disease: an environmental cause? Science 229: 257–258.
Lewin R (1987) Environmental hypothesis for brain disease strengthened by new data. Science 237: 483–484.
Makhaeva G, Malygin V, Martynov I (1987) Organophosphorus pesticides delayed neurotoxicity. Agrochimia (Russ) 2: 103–124.
Makhaeva G, Malygin V, Martynov I (1988) The biochemical mechanisms of organophosphorus pesticides toxicity. Pestycydy 3: 39.
Makino Y, Ohata S, Tachikawa D, Hirobe M (1988) Presence of tetra-hydroisoquino-line and 1-methyl-tetrahydro-isoquinoline in foods: compounds related to Parkinson’s disease. Life Sci 43: 373–378.
Marsden C, Sandler M (1986) The MPTP story: an introduction. J Neurol Trans Suppl 20: 13.
Mayer R, Kindt M, Heikkila R (1986) Prevention of the nigrostriatal toxicity of MPTP by inhibitors of 3,4–dihydroxyphenylethylamine. J Neurochem 47: 1073–1079.
Melamed E, Rosenthal J, Cohen O, Globus M, Uzzan A (1985) Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP. Eur J Pharm 116: 179–181.
Melnikov N, Novikov E, Kchaskin B (1975) Chemistry and biological activity of dipyridils and their derivatives. Moscow, Chimia (Russ) p 104.
Mizuno Y, Sone N, Saitoh T (1987) Effect of MPTP and MPP+ ion on activities of the enzymes in the electron transport system in mouse brain. J Neurochem, 48: 1787–1793.
Naoi M, Matsuura S, Parvez H, Takahashi T, Hirata Y, Minami M, Nagatsu T (1989) Oxidation of N-methyl-l,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase. J Neurochem, 52: 653–655.
Nicklas W, Vyas J, Heikkila R (1985) Inhibition of NADH-linked oxidation in brain mitochondria by MPP, a metabolite of neurotoxin MPTP. Life Sci 36: 2503–2508.
Nicklas W, Youngster S, Kindt M, Heikkila R (1987) MPTP, MPP + and mitochondrial function. Life Sci. 40: 721–729.
Oreland L, Goherics C (1986) Brain and brain monoamine oxidase in aging and dementia of Alzheimer’s type. Progress in Neuro-Psychopharm Biol Psychiatry 10: 533–540.
Perry T, Yong V, Jones K, Wall R, Clavier R, Foulks J, Wright J (1985) Effects of MPTP and its metabolite, MPP+ ion, on dopaminergic nigrostriatal neurons in the mouse. Neurosci Lett 58: 321–326.
Perry T, Yong V, Wall R, Jones K (1986a) Paraquat and two endogenous analogues of the neurotoxic substance MPTP do not damage dopamineragic nigrostriatal neurons in the mouse. Neurosci Lett 69: 285–289.
Perry T, Yong V, Jones K, Wright J (1986b) Manipulation of glutathion contents fails to alter dopaminergic nigrostriatal neurotoxicity of MPTP in the mouse. Neurosci Lett 70: 261–265.
Peterson L, Caldera P, Trevor A, Chiba K, Castagnoli N (1985) Studies on the l-methyl-4-phenyl-2,3-dihydropyridinim species 2,3-MPDP +, the monoamine oxidase catalysed oxidation product of the nigrostriatal toxin MPTP. J Med Chem 28: 1432–1436.
Pileblad E, Carlsson A (1985) Catecholamine-uptake inhibitors prevent the neurotoxicity of MPTP in mouse brain. Neuropharmacology 24: 689–692.
Ramsay R, Dadgar J, Trevor A, Singer T (1986a) Energy-driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci 39: 581–588.
Ramsay R, Salach J, Dadgar J, Singer T (1986b) Inhibition of mitochondrial NADH dehydrogenase by pyridine derivatives and its possible relation to experimental and idiopathic parkinsonism. Biochem Biophys Res Comm 135: 269–275.
Ramsay R, Singer T (1986c) Energy-dependent uptake of MPP +, the neurotoxic metabolite of MPTP, by mitochondria. J Biol Chem 261: 7585–7587.
Ramsay R, Koerberg S, Singer T (1987) Stopped-flow studies on the mechanism of oxidation of MPTP by bovine monoamine oxidase B. Biochemistry 26: 3045–3050.
Reinbold A (1986) Plant growth regulators with retardant properties. Agrochimia (Russ) 5: 116.
Riachi N, Arora P, Sayre L, Harik S (1988) Potent neurotoxic fluorinated MPTP analogs as potential probes in models of Parkinson disease. J Neurochem 50: 1319–1321.
Ricourte G, Langston J, Delanney L (1985) Dopamine uptake blockers protect against the dopamine depleting effect of MPTP in the mouse striatum. Neurosci Lett 59: 264.
Ricourte G, Langston J, Delanney L, Irwin I, Peroutka S, Forno L (1987) Fate of nigrostriatal neurons in young mature mice given MPTP: a neurochemical and morphological reassessment. Brain Res 403: 43–51.
Rios C, Tapia R (1987) Changes in lipid peroxidation induced by MPTP and MPP + in mouse brain homogenates. Neurosci Lett 77: 321–326.
Ross S (1987) Pharmacological and toxicological exploitation of amine transports. TIPS, 8: 22–231.
Rosetti Z, Sotgiu A, Sharp D, Hadjiconstantinou M, Neff N (1988) MPTP and free radicals in vitro. Biochem Pharmacol 37: 4573–4574.
Russ H, Przuntek H, Henning I, Pindrur U (1986) The protective effect of budipine against the nigrostriatal degeneration caused by MPTP and the interaction at the MPTP receptor binding site. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 449–453.
Salach J, Singer T, Castagnoli N, Trevor A (1984) Oxidation of the neurotoxic amine MPTP by monoamine oxidase A and B and suicide inactivation of the enzymes by MPTP. Biochem Biophys Res Comm 125: 831–835.
Schwartzbeck R (1974) Cyperquat, l-methyl-4-phenylpyridinium chloride, for the control of nutsedge (Cyperus spp.). Proc 12th British Confer pp 851–856.
Sershen H, Debber E, Lajtha A (1987) Effect of ascorbic acid on the synaptosomal uptake of [H-3] MPP +, [H-3] dopamine and [C-14] GABA. J Neurosci Res 17: 298–301.
Seto Y, Shinohara T (1987) Inhibitory effect of paraquat and its related compounds on the acetylcholinesterase activities of human erythrocytes and electric eel (.Electrophorus electricus). Agric Biol Chem 51: 2131–2138.
Singer T, Salach J, Crabtree D (1985) Reversible inhibition and mechanism-based inactivation of monoamine oxidase by MPTP. Biochem Biophys Res Comm 127: 707–712.
Singer T, Salach J, Castagnoli N, Trevor A (1986) Interactions of the neurotoxic amine MPTP with monoamine oxidase. Biochem J 135: 785–789.
Singer T, Castagnoli N, Ramsay R, Trevor A (1987) Biochemical events in development of parkinsonism induced by MPTP. J Neurochem 49: 1–8.
Singh Y, Swanson E, Sokolowski E, Kutty P, Krishna G (1988) MPTP and MPTP analogs induced cell death in cultured rat hepatocytes involving the formation of pyridinium metabolites. Toxicol Appl Pharmacol 96: 347–359.
Sinha B, Singh Y, Krishna G (1986) Formation of superoxide and hydroxyl radicals from l-methyl-4-phenylpyridinium ion (MPP +): reductive activation by NADPH cytochrome P-450 reductase. Biochem Biophys Res Comm 135: 583–588.
Shen R, Abell C, Gessner W, Brossi A (1985) Serotonergic conversion of MPTP and dopaminergic accumulation of MPP +. FEBS Lett 189: 225–230.
Shen R, Abell C, Gessner W, Brossi A (1986) Hypothalamus uptake of [3 H] MPTP and striatal uptake of [H-3] MPP + in rat brain synaptosomes. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxine Producing a Parkinsonian Syndrome. Academic Press, New York, pp 563–567.
Shimanskaya M, Leitis L (1989) Pesticides based on pyridine derivatives. Chim Heterocycl Compounds J (Russ) 5: 579–587.
Shinochara T, Seto Y (1986) In vitro inhibition of acetylcholinesterase by paraquat. Agric Biol Chem 50: 255–256.
Snyder S, D’Amato R (1985) Predicting Parkinson’s disease. Nature 317: 198–199.
Snyder S, D’Amato R, Nue G, Javitch J (1986) Selective uptake of MPP + by dopamine neurons is required for MPTP toxicity: studies in brain synaptosomes and PC-12 cells. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 191–201.
Spencer P, Nunn P, Hugon J, Ludloph A, Ross S, Roy D, Robertson R (1987) Guam amytrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237: 517–522.
Summers L (1980) The Bipyridinium Herbicides. Academic Press, London, pp 1–423.
Sundeen I, Frederic P (1979) 4-(2-Phenyl)-ethyl-N-alkenyl-(or alkynyl)-1,2,3,6-tetrahydropyridines and their salts with acids. Ger Offen 2.904.451 (c. CO7d 213/24).
Sundstrom E, Stromberg I, Tsutsumi T, Olson L, Jonsson G (1987) Studies on the effect of MPTP on central catecholamine neurons in mice. Comparison with three other strains of mice. Brain Res 405: 26–38.
Takamidoh H, Naoi M, Nagatsu T (1987) Inhibition of type A monoamine oxidase by l-methyl-4-phenylpyridine. Neurosci Lett 73: 293–297.
Tanner C (1989) The role of environmental toxin in the etiology of Parkinson’s disease. TINS 12: 49–54.
Tilson H, Burns R, Freed C, Heikkila R, Fuller R (1986) Animal models of MPTP toxicity: a panel discussion. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 149–158.
Tkachenko S, Kalashnikov V, Lermontova N, Solyakov L, Sablin S, Bachurin S (1988a) Comparative study of pyridinium herbicides neurotoxicity mechanisms. Pestycydy 3: 55.
Tkachenko S, Kalashnikov V, Mashkova I, Bachurin S (1988b) Regioselective synthesis of 2-and 4-aryl (hetaryl) pyridines. Abstracts Conference on Chemistry and Technology of Pyridine Containing Pesticides ( USSR ), Chernogolovka (Russ) pp 131–132.
Tkachenko S, Kalashnikov V, Kalashnikova I, Mukhin S, Lermontova N, Solyakov L, Sablin S, Bachurin S (1989) Regioselective synthesis of physiologically active 4-aryl-, 4-styrylpyridines and its hydrogenate derivatives. Abstracts Conferenace on Chemistry of Physiologically Active Substances ( USSR ), Chernogolovka (Russ) p 126.
Tollenaere G, Moereels H, Raymaekers L (1979) Atlas of three dimensional structure of drugs. Elsevier North-Holland Biochemical Press, Amsterdam, New York, Oxford pp 61–84.
Trevor A, Castagnoli N, Singer T (1988) The formation of reactive intermediates in the MAO-catalyzed oxidation of the nigrostriatal toxin MPTP. Toxicology 49: 513–519.
Trevor A, Chiba K, Yu E, Caldera P, Castagnoli K, Castagnoli N, Peterson L, Salach J, Singer T (1986) Metabolism of MPTP in vitro: the intermediate role of 2-3-MPDP + and studies on its chemical and biochemical reactivity. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 161–172.
Vartanyan P (1984) Synthesis and biological activity of noncondensed cyclic derivatives of piperidine. Chim Pharm J (Russ) 18: 1294–1309.
Vein A, Golubev V, Berzinsh Y (1981) Parkinsonism. ( Russ ), Riga Zinatne pp 1–325.
Venkov A, Lukanov L, Mollov N (1988) 2-Acyl-l,2,3,4-tetrahydroisoquinolines as plant growth regulators. Pestycydy 3: 57.
Voloshin M, Lukhanina E, Kolomiets B, Burchinskaya L, Nosenko N, Kuznetzov N (1989) Inhibition and excitation processes in thalamus motor nuclei neurons of cat in norm and after the nigrostriatal dopaminergic system injury produced by MPTP. Neurophysiol (Russ) 21: 620–628.
Wilkening D, Vernier V, Arthand L, Treasy G, Kenney J, Nickolson V, Clark R, Smith D, Boswel G (1986) A Parkinson-like neurologic deficit in primates is caused by a novel 4-substituted piperidine. Brain Res 368: 239–246.
Yong V, Perry T, Krisman A (1986) Depletion of glutathion brainstem of mice caused by MPTP is prevented by antioxidant pretreatment. Neurosci Lett 63: 56–60
Youngster S, Duvoisin R, Hess A (1986) l-Methyl-4-(2′-methyl-phenyl)-l,2,3,6-tetrahydropyridine is a more potent dopaminergic neurotoxin than MPTP in mice. Eur J Pharm 122: 283–287.
Youngster S, Heikkila R (1986) Structure-activity studies on the mechanism of MPTP-MPP + -induced neurotoxicity. In: Markey S, Castagnoli N, Trevor A, Kopin I (eds) MPTP: A Neurotoxin Producing a Parkinsonian Syndrome. Academic Press, New York, pp 503–508.
Youngster S, Sonsalla P, Heikkila R (1987) Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin MPTP. J Neurochem 48: 929–934.
Zimmermann D, Cantrell B, Reel J, Hemrick-Luecke S, Fuller R (1986) Characterization of the neurotoxic potential of m-methoxy-MPTP and the use of its N-ethyl analogue as a means of avoiding exposure to a possible Parkinsonism-causing agent. J Med Chem 29: 1517–1620.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Bachurin, S.O., Tkachenko, S.E., Lermontova, N.N. (1991). Pyridine Derivatives: Structure-Activity Relationships Causing Parkinsonism-Like Symptoms. In: Ware, G.W. (eds) Reviews of Environmental Contamination and Toxicology. Reviews of Environmental Contamination and Toxicology, vol 122. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3198-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3198-1_1
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7829-0
Online ISBN: 978-1-4612-3198-1
eBook Packages: Springer Book Archive